EnWave Signs Equipment Purchase Agreement with Calbee Inc. to Expand Commercial Manufacturing Capacity

June 29, 2020

VANCOUVER, JUNE 19TH 2020, 6:00 AM

EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today provides a corporate update on its recent corporate activities, operations, and market evolution.

Cannabis Installation Update

EnWave has successfully installed a 60kW Radiant Energy Vacuum (“REV”) processing line for its licensed partner, The Green Organic Dutchman Holdings Ltd. (“TGOD”) in Ancaster, Ontario. The Company is working through the final stages of training TGOD personnel on the commercial use of EnWave’s machinery for the dehydration of cannabis and expects to begin accruing royalties henceforth. The installation and training were delayed due to the impacts of COVID-19, but with improving conditions, EnWave was able to send qualified personnel within Canada to complete this installation and training.

The Company is also in the final stages of fabricating two 120kW REV™ machines for Aurora Cannabis Inc. (“Aurora”). In early 2020, Aurora contracted EnWave to make several upgrades to its two REV™ machines in order to satisfy revised requirements, which subsequently elongated the manufacturing timeline but resulted in additional payments to the Company.

EnWave has also offered to complete remote 10kW REV™ machine installations to Cann Group in Australia and Helius Therapeutics in New Zealand, both current royalty partners. The Company hopes to confirm these installations in the near term.

REV™ Technology Business Development Update

The Company has continued to advance its sales and business development plan despite many of the headwinds presented by the global economic downturn propagated by the COVID-19 pandemic. Despite the challenges caused by COVID-19, the Company secured three new technology evaluation agreements with machine rentals through the last three months. There are several existing EnWave royalty partners that have 10kW machines installed under license that are evaluating the scale-up to larger REVTM machines, and the Company anticipates securing new purchase contracts for repeat and large-scale REV™ machines as the global economy begins to recover and international travel restrictions are lightened.

NutraDried Update

NutraDried has expanded its product offering of better-for-you, all-natural cheese snacks with the launch of a new white cheddar with black pepper flavour. The new flavour is currently being sold online and the Company plans to expand to retail distribution in the coming months.

NutraDried has also taken steps to leverage its manufacturing capabilities to produce shelf-stable cheese snacks for private label and ingredient opportunities. The Company has already secured several distribution opportunities for bulk shelf-stable cheese products and is pursuing a wide number of additional contract manufacturing opportunities for this new product offering. The contract manufacturing revenues will complement NutraDried’s branded snack offerings to drive volume and create operating leverage with the objective of enhancing gross margin in that business unit.

Grant of Equity Incentive Instruments

The Company has granted an aggregate of 500,000 incentive stock options pursuant to the Company’s Stock Option Plan (the “Plan”) to certain directors and officers of the Company (the “Incentive Options”). The Incentive Options are exercisable at a price of $1.25 per share and are exercisable for a term of five years expiring on June 17, 2025. The Incentive Options have been structured with performance-based vesting conditions in accordance with the Plan, and will vest upon the later of a) eighteen months from the date of grant, or b) when the Company’s share price on the TSX Venture Exchange (“TSXV”) achieves a volume-weighted average price (“VWAP”) for twenty consecutive trading days of $1.50 or greater. The Incentive Options are subject to approval by the TSXV.

The Company has granted an aggregate of 260,000 restricted share rights pursuant to the Company’s Restricted Share Rights Plan to certain directors and officers of the Company (the “RSRs”). The RSRs will vest three years from the date of award for each independent director, and will vest three years from the date of award and subject to the Company’s share price on the TSXV achieving a VWAP for twenty consecutive trading days of $1.50 or greater for the senior management of the Company. If the VWAP vesting performance condition is not met within the three-year life of the instrument, then no common shares of the Company will be issued in respect of the RSRs. The RSRs are subject to approval by the TSXV.

The Company’s Board of Directors consulted with a third-party executive compensation specialist to conduct a benchmarking study as part of the evaluation and approval process for the equity incentive instruments. The resulting performance-based vesting conditions implemented were designed to create proper alignment between management incentives and creating shareholder value.

DOWNLOAD PRESS RELEASE

エンウェーブについて

バンクーバーを拠点とする先端技術企業、エンウェーブ・コーポレーションは、有機物を正確に脱水する革新的な独自手法であるラジアント・エナジー・バキューム(「REV™」)を開発した。EnWave社はさらに、REV™技術を使って大麻を均一に乾燥・除染する特許取得済みの方法を開発し、収穫から大麻製品が市場に出回るまでの時間を短縮しました。

REV™技術の商業的可能性は実証されており、合法的な大麻を含む食品、医薬品分野の複数の市場垂直方向で急速に成長しています。エンウェーブの戦略は、REV™技術の使用に関して、複数の垂直市場において革新的で破壊的な企業とロイヤリティを伴う商業ライセンスを締結することです。現在までに30件以上のロイヤリティ付きライセンスを締結している。これらのライセンスに加え、エンウェーブは有限責任会社NutraDried Food Company, LLCを設立し、MoonCheese®ブランドを含む米国内の天然乳製品スナック製品の製造、マーケティング、販売を行っている。

エンウェーブは、凍結乾燥よりも迅速かつ低コストで、風乾や噴霧乾燥よりも優れた最終製品品質を実現するREV™を、食品および生物材料の分野における新たな脱水標準として導入しました。
1.nutraREV®は、栄養、味、食感、色を高いレベルで維持しながら、食品を迅速かつ低コストで乾燥させるために食品産業で使用されています。
2.quantaREV®は、連続的な大量低温乾燥に使用されています。

エンウェーブの詳細については、www.enwave.net をご覧ください。

エンウェーブ・コーポレーション

ブレント・チャールトン、CFA
社長兼CEO

詳細はこちら:

Brent Charleton, CFA
社長兼 CEO 電話: +1 (778) 378-9616
E-mail:bcharleton@enwave.net

Dan Henriques, CA, CPA,
最高財務責任者 電話: +1 (604) 835-5212
E-mail:dhenriques@enwave.net

将来予測情報に関する記述のセーフハーバー:本プレスリリースには、経営陣の期待、見積もり、予測に基づく将来の見通しに関する情報が含まれている場合があります。当社の成長戦略、製品開発、市場での地位、予想される支出、クロージング後に期待されるシナジー効果に関する記述を含め、将来に対する期待や予測に言及する記述はすべて、将来の見通しに関する記述です。本リリースで言及されている第三者の主張はすべて、その正確性を保証するものではありません。本リリースに記載されている市場情報に関する第三者の言及はすべて、当社が独自に一次調査を行ったものではないため、正確性を保証するものではありません。これらの記述は将来の業績を保証するものではなく、多くのリスク、不確実性および仮定を含んでいます。当社は、実際の結果と大きく異なる可能性のある重要な要因を特定するよう努めましたが、予想、見積りまたは意図したとおりの結果とならないその他の要因が存在する可能性があります。実際の結果や将来の事象は、かかる記述で予想されたものとは大きく異なる可能性があるため、かかる記述が正確であることを保証するものではありません。したがって、読者は将来の見通しに関する記述を過度に信頼すべきではありません。


TSXベンチャー取引所およびその規制サービスプロバイダー(この用語はTSXベンチャー取引所の方針で定義されています)は、本リリースの妥当性または正確性について責任を負いません。